Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 1
2005 1
2006 2
2007 2
2008 2
2009 4
2010 6
2011 4
2012 7
2013 6
2014 9
2015 11
2016 4
2017 5
2018 4
2019 6
2020 4
2021 7
2022 13
2023 9
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
p38 MAPK inhibitors: a patent review (2012 - 2013).
Bühler S, Laufer SA. Bühler S, et al. Among authors: laufer sa. Expert Opin Ther Pat. 2014 May;24(5):535-54. doi: 10.1517/13543776.2014.894977. Epub 2014 Mar 10. Expert Opin Ther Pat. 2014. PMID: 24611721 Review.
The Cysteinome of Protein Kinases as a Target in Drug Development.
Chaikuad A, Koch P, Laufer SA, Knapp S. Chaikuad A, et al. Among authors: laufer sa. Angew Chem Int Ed Engl. 2018 Apr 9;57(16):4372-4385. doi: 10.1002/anie.201707875. Epub 2018 Feb 2. Angew Chem Int Ed Engl. 2018. PMID: 28994500 Review.
The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma.
Spahn S, Kleinhenz F, Shevchenko E, Stahl A, Rasen Y, Geisler C, Ruhm K, Klaumuenzer M, Kronenberger T, Laufer SA, Sundberg-Malek H, Bui KC, Horger M, Biskup S, Schulze-Osthoff K, Templin M, Malek NP, Poso A, Bitzer M. Spahn S, et al. Among authors: laufer sa. Nat Commun. 2024 Feb 12;15(1):1287. doi: 10.1038/s41467-024-45247-6. Nat Commun. 2024. PMID: 38346946 Free PMC article.
A patent review of MAPK inhibitors (2018 - present).
Wydra VR, Ditzinger RB, Seidler NJ, Hacker FW, Laufer SA. Wydra VR, et al. Among authors: laufer sa. Expert Opin Ther Pat. 2023 Jan-Jun;33(6):421-444. doi: 10.1080/13543776.2023.2242584. Epub 2023 Aug 1. Expert Opin Ther Pat. 2023. PMID: 37501497 Review.
Inhibitors of c-Jun N-terminal kinases: an update.
Koch P, Gehringer M, Laufer SA. Koch P, et al. Among authors: laufer sa. J Med Chem. 2015 Jan 8;58(1):72-95. doi: 10.1021/jm501212r. Epub 2014 Dec 8. J Med Chem. 2015. PMID: 25415535 Review.
c-Jun N-terminal kinase inhibitors: a patent review (2010 - 2014).
Gehringer M, Muth F, Koch P, Laufer SA. Gehringer M, et al. Among authors: laufer sa. Expert Opin Ther Pat. 2015;25(8):849-72. doi: 10.1517/13543776.2015.1039984. Epub 2015 May 19. Expert Opin Ther Pat. 2015. PMID: 25991433 Review.
106 results